Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (291-300 of 436) with videos related to

Pageof 44
Sort By:
American Heart Journal|August 2, 2017
Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohortRong Jiang, Michael A Babyak, Beverly H Brummett, et al.
Clinical Chemistry|December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes studyÅxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
American Heart Journal|December 9, 2008
Clopidogrel use and bleeding after coronary artery bypass graft surgeryJohn Hyung-Jun Kim, L Kristin Newby, Robert M Clare, et al.
American Heart Journal|March 1, 2006
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trialAdam B Greenbaum, Cindy L Grines, John A Bittl, et al.
Journal of Psychosomatic Research|January 22, 2017
Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemiaJacob P Feigal, Stephen H Boyle, Zainab Samad, et al.
Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
Cardiorenal Medicine|January 14, 2025
EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart FailureNatalie Kreitzer, Nancy M Albert, Alpesh N Amin, et al.
Pageof 44

Showing results (291-300 of 436) with videos related to

Sort By:
Pageof 44
American Heart Journal|August 2, 2017
Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohortRong Jiang, Michael A Babyak, Beverly H Brummett, et al.
Clinical Chemistry|December 1, 2011
Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes studyÅxel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
American Heart Journal|September 18, 2012
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes-insights from the PLATelet inhibition and patient Outcomes (PLATO) trialJan H Cornel, Richard C Becker, Shaun G Goodman, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
American Heart Journal|December 9, 2008
Clopidogrel use and bleeding after coronary artery bypass graft surgeryJohn Hyung-Jun Kim, L Kristin Newby, Robert M Clare, et al.
American Heart Journal|March 1, 2006
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trialAdam B Greenbaum, Cindy L Grines, John A Bittl, et al.
Journal of Psychosomatic Research|January 22, 2017
Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemiaJacob P Feigal, Stephen H Boyle, Zainab Samad, et al.
Circulation|June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trialKenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
Cardiorenal Medicine|January 14, 2025
EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart FailureNatalie Kreitzer, Nancy M Albert, Alpesh N Amin, et al.
Pageof 44